Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials by Kristensen, SL, Rørth, R, Jhund, PS, Docherty, KF, Sattar, N, Preiss, D, Køber, L, Petrie, MC, McMurray, JJV

Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study by Conrad, N, Molenberghs, G, Verbeke, G, Zaccardi, F, Lawson, C, Friday, JM, Su, H, Jhund, PS, Sattar, N, Rahimi, K, Cleland, JG, Khunti, K, Budts, W, McMurray, JJV